To RAS or Not to RAS? The Evidence for and Cautions with Renin-Angiotensin System Inhibition in Patients with Diabetic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

To RAS or Not to RAS? The Evidence for and Cautions with Renin-Angiotensin System Inhibition in Patients with Diabetic Kidney Disease

Published:2013-04-09 Issue:5 Volume:33 Page:496-514
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

St. Peter Wendy L.¹²,Odum Lauren E.³,Whaley-Connell Adam T.⁴⁵

Affiliation:

1. College of Pharmacy; University of Minnesota; Minneapolis Minnesota

2. Chronic Disease Research Group; Minneapolis Medical Research Foundation; Minneapolis Minnesota

3. Division of Pharmacy Practice and Administration; University of Missouri Kansas City School of Pharmacy; Columbia Missouri

4. Harry S. Truman Memorial Veterans Hospital; Columbia Missouri

5. Division of Nephrology and Hypertension; University of Missouri-Columbia School of Medicine; Columbia Missouri

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1232/fullpdf

Reference78 articles.

1. Standards of medical care in diabetes 2013;American Diabetes Association;Diabetes Care,2013

2. Temporal trends in the prevalence of diabetic kidney disease in the United States;De Boer;JAMA,2011

3. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial;The Diabetes Control and Complications (DCCT) Research Group;Kidney Int,1995

4. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study;The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group;JAMA,2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway;Chinese Journal of Integrative Medicine;2024-07-23

2. Ginsenoside Rg3 has effects comparable to those of ginsenoside re on diabetic kidney disease prevention in db/db mice by regulating inflammation, fibrosis and PPARγ;Molecular Medicine Reports;2023-03-03

3. Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study;JMIR Medical Informatics;2021-05-11

4. Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study (Preprint);2021-01-31

5. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial;Trials;2020-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3